Drugs / DHEA
last change Dec 2015 re-read 2 minutes ago

DHEA

Developed for
ovarian dysfunction

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT02099916 Comparator Oct → Dec 2014 ovarian dysfunction University of Athens Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DHEA ClinicalTrials.gov intervention name — accepted as the source's own label NCT02099916
Route Oral “DHEA 25 mg PO tid for 12 weeks.” NCT02099916